tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Integral Diagnostics Reports Robust FY25 Financial Results and Successful Merger Integration

Story Highlights
  • Integral Diagnostics Ltd. reported a 33.7% revenue increase and 38.3% EBITDA growth for FY25.
  • The successful merger with Capitol Health exceeded synergy expectations, enhancing IDX’s operational scale.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Integral Diagnostics Reports Robust FY25 Financial Results and Successful Merger Integration

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Integral Diagnostics Ltd. ( (AU:IDX) ) has provided an announcement.

Integral Diagnostics Ltd. reported strong financial results for FY25, marked by a 33.7% increase in consolidated revenue to $628.0 million and a 38.3% rise in operating EBITDA to $126.5 million. The merger with Capitol Health has been successfully integrated, resulting in synergies of $7.0 million, exceeding initial expectations. The company’s balance sheet remains robust with reduced leverage, and it declared a fully franked final dividend of 4.0 cents per share. This strategic merger has enhanced IDX’s operational scale and network, providing a stronger platform for clinical outcomes and future growth.

The most recent analyst rating on (AU:IDX) stock is a Buy with a A$3.30 price target. To see the full list of analyst forecasts on Integral Diagnostics Ltd. stock, see the AU:IDX Stock Forecast page.

More about Integral Diagnostics Ltd.

Integral Diagnostics Ltd. is a company operating in the healthcare industry, primarily focusing on diagnostic imaging services. The company is known for its comprehensive range of diagnostic imaging services and has a significant market presence in Australia.

Average Trading Volume: 1,043,981

Technical Sentiment Signal: Buy

Current Market Cap: A$998.1M

See more insights into IDX stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1